Signaling pathways controlling skeletal muscle mass

Abstract The molecular mechanisms underlying skeletal muscle maintenance involve interplay between multiple signaling pathways. Under normal physiological conditions, a network of interconnected signals serves to control and coordinate hypertrophic and atrophic messages, culminating in a delicate balance between muscle protein synthesis and proteolysis. Loss of skeletal muscle mass, termed “atrophy”, is a diagnostic feature of cachexia seen in settings of cancer, heart disease, chronic obstructive pulmonary disease, kidney disease, and burns. Cachexia increases the likelihood of death from these already serious diseases. Recent studies have further defined the pathways leading to gain and loss of skeletal muscle as well as the signaling events that induce differentiation and post-injury regeneration, which are also essential for the maintenance of skeletal muscle mass. In this review, we summarize and discuss the relevant recent literature demonstrating these previously undiscovered mediators governing anabolism and catabolism of skeletal muscle.

[1]  B. Drake Differential Response , 2013 .

[2]  J. Darlix,et al.  Conducting the initiation of protein synthesis: the role of eIF4G , 2003, Biology of the cell.

[3]  Dudley Lamming,et al.  Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.

[4]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[5]  Da-Zhi Wang,et al.  Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. , 2004, The Journal of clinical investigation.

[6]  A. Sanchez,et al.  eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle☆ , 2013, The International Journal of Biochemistry & Cell Biology.

[7]  M. Hall,et al.  Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy , 2013, Skeletal Muscle.

[8]  B. Spiegelman Peroxisome Proliferator-Activated Receptor-Coactivator 1 ( PGC-1 ) : Transcriptional Coactivator and Metabolic Regulator , 2003 .

[9]  N. LeBrasseur,et al.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.

[10]  G. Yancopoulos,et al.  Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy , 2004, Molecular and Cellular Biology.

[11]  D. Allen,et al.  Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. , 2011, American journal of physiology. Cell physiology.

[12]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[13]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[14]  M. Greenwood,et al.  Peptide and non-peptide G-protein coupled receptors (GPCRs) in skeletal muscle , 2005, Peptides.

[15]  P. Freemont,et al.  The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.

[16]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Kasuga,et al.  Regulation of eIF-4E BP1 Phosphorylation by mTOR* , 1997, The Journal of Biological Chemistry.

[18]  T. Hunter,et al.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. , 1999, Science.

[19]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Shuo Lin,et al.  Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. , 2013, Cell metabolism.

[21]  D. Glass,et al.  Molecular mechanisms and treatment options for muscle wasting diseases. , 2011, Annual review of pharmacology and toxicology.

[22]  S. Bodine,et al.  The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. , 2008, American journal of physiology. Endocrinology and metabolism.

[23]  A. Csibi,et al.  MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines* , 2009, Journal of Biological Chemistry.

[24]  Valerie Horsley,et al.  Calcineurin Activity Is Required for the Initiation of Skeletal Muscle Differentiation , 2000, The Journal of cell biology.

[25]  M. E. Lynch,et al.  Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. , 1994, Metabolism: clinical and experimental.

[26]  During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation , 2009, The Journal of cell biology.

[27]  J. Devesa,et al.  Myostatin regulates cell survival during C2C12 myogenesis. , 2001, Biochemical and biophysical research communications.

[28]  H. Katus,et al.  Phosphorylation of Eukaryotic Translation Initiation Factor 2Bε by Glycogen Synthase Kinase-3β Regulates β-Adrenergic Cardiac Myocyte Hypertrophy , 2004, Circulation research.

[29]  K. Esser,et al.  FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner. , 2009, American journal of physiology. Cell physiology.

[30]  D. Dias-Santagata,et al.  The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. , 2008, Molecular cell.

[31]  S. Bodine,et al.  Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. , 2007, Journal of applied physiology.

[32]  Adrian V. Lee,et al.  Insulin-Like Growth Factor I-Induced Degradation of Insulin Receptor Substrate 1 Is Mediated by the 26S Proteasome and Blocked by Phosphatidylinositol 3′-Kinase Inhibition , 2000, Molecular and Cellular Biology.

[33]  Jiong Wu,et al.  Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1 , 2002, Molecular and Cellular Biology.

[34]  I. Nonaka,et al.  Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading , 2009, Molecular and Cellular Biology.

[35]  Eric Karsenti,et al.  Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein , 2002, Journal of Cell Science.

[36]  M. Palacín,et al.  Evidence for a Mitochondrial Regulatory Pathway Defined by Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α, Estrogen-Related Receptor-α, and Mitofusin 2 , 2006, Diabetes.

[37]  C. Gregorio,et al.  Functional properties of the titin/connectin-associated proteins, the muscle-specific RING finger proteins (MURFs), in striated muscle , 2006, Journal of Muscle Research & Cell Motility.

[38]  M. Febbraio,et al.  FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle* , 2007, Journal of Biological Chemistry.

[39]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[40]  V. Hughes,et al.  Sarcopenia: current concepts. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[41]  E. Ganio,et al.  Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells , 2013, Skeletal Muscle.

[42]  A. Gingras,et al.  4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.

[43]  T. Haystead,et al.  PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. , 1997, Advances in enzyme regulation.

[44]  D. Sabatini,et al.  mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin , 2013, Science.

[45]  S. Hatakeyama,et al.  Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.

[46]  G. Pavlath,et al.  Regulation of the Growth of Multinucleated Muscle Cells by an Nfatc2-Dependent Pathway , 2001, The Journal of cell biology.

[47]  N. Offner,et al.  The initiation factor eIF3‐f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy , 2008, The EMBO journal.

[48]  S. Gygi,et al.  Genomic and Proteomic Profiling Reveals Reduced Mitochondrial Function and Disruption of the Neuromuscular Junction Driving Rat Sarcopenia , 2012, Molecular and Cellular Biology.

[49]  Michel Georges,et al.  A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle , 1997, Nature Genetics.

[50]  H. Horiuchi Seven-transmembrane receptors , 2015 .

[51]  A. Goldberg,et al.  Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy* , 2010, The Journal of Biological Chemistry.

[52]  C. Gregorio,et al.  Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.

[53]  P. Hasselgren,et al.  Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. , 2010, The international journal of biochemistry & cell biology.

[54]  Se-Jin Lee,et al.  Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Durigan,et al.  Joint Inflammation Alters Gene and Protein Expression and Leads to Atrophy in the Tibialis Anterior Muscle in Rats , 2011, American journal of physical medicine & rehabilitation.

[56]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[57]  W. Frontera,et al.  IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.

[58]  K. Pelin,et al.  Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. , 2001, Journal of molecular biology.

[59]  Se-Jin Lee,et al.  Myostatin and the control of skeletal muscle mass. , 1999, Current opinion in genetics & development.

[60]  Wen Dui,et al.  MST1, a key player, in enhancing fast skeletal muscle atrophy , 2013, BMC Biology.

[61]  Y. Pi,et al.  Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders , 2013, Nature.

[62]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[63]  E. Wouters,et al.  NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy. , 2012, American journal of respiratory cell and molecular biology.

[64]  Seumas McCroskery,et al.  Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.

[65]  D. Glass,et al.  The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. , 2011, Developmental cell.

[66]  C. Mammucari,et al.  Smad2 and 3 transcription factors control muscle mass in adulthood. , 2009, American journal of physiology. Cell physiology.

[67]  D. Béchet,et al.  Leucine Limitation Induces Autophagy and Activation of Lysosome-dependent Proteolysis in C2C12 Myotubes through a Mammalian Target of Rapamycin-independent Signaling Pathway* , 2000, The Journal of Biological Chemistry.

[68]  Metformin, metabolic stress, and mitochondria. Focus on "A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells". , 2012, American journal of physiology. Cell physiology.

[69]  W. Frontera,et al.  IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.

[70]  Zhijian Lu,et al.  Regulation of GDF-8 signaling by the p38 MAPK. , 2005, Cellular signalling.

[71]  D. Sabatini,et al.  Redox Regulation of the Nutrient-sensitive Raptor-mTOR Pathway and Complex* , 2005, Journal of Biological Chemistry.

[72]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[73]  B. Spiegelman,et al.  Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging , 2009, Proceedings of the National Academy of Sciences.

[74]  Stefan Offermanns,et al.  Mammalian G proteins and their cell type specific functions. , 2005, Physiological reviews.

[75]  J. Blenis,et al.  TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function , 2003, Current Biology.

[76]  W. Bauman,et al.  Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor. , 2009, Biochemical and biophysical research communications.

[77]  K. Chihara,et al.  Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line. , 2008, Biochimica et biophysica acta.

[78]  Se-Jin Lee,et al.  Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.

[79]  S. Walrand,et al.  Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β‐adrenoceptor stimulation in mice , 2010, The Journal of physiology.

[80]  Jun Sub Park,et al.  MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling , 2013, Nature Communications.

[81]  E. Kudryashova,et al.  Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. , 2005, Journal of molecular biology.

[82]  M. Azain,et al.  Myostatin knockout in mice increases myogenesis and decreases adipogenesis. , 2002, Biochemical and biophysical research communications.

[83]  C. Pellegrino,et al.  AN ELECTRON MICROSCOPE STUDY OF DENERVATION ATROPHY IN RED AND WHITE SKELETAL MUSCLE FIBERS , 1963, The Journal of cell biology.

[84]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[85]  G. Lynch,et al.  Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. , 2008, Physiological reviews.

[86]  S. Gygi,et al.  Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy , 2012, The Journal of cell biology.

[87]  P. Hasselgren,et al.  Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.

[88]  E. Hafen,et al.  Autonomous Control of Cell and Organ Size by CHICO, a Drosophila Homolog of Vertebrate IRS1–4 , 1999, Cell.

[89]  Robert J. Schwartz,et al.  Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[90]  T. Tarragó,et al.  Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth. , 1997, Cancer letters.

[91]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[92]  V. Almendro,et al.  The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia. , 2007, International journal of oncology.

[93]  L. Tessitore,et al.  Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. , 1995, The Journal of clinical investigation.

[94]  D. Allen,et al.  Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli , 2011, Molecular and Cellular Endocrinology.

[95]  A. Marette,et al.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.

[96]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[97]  J. Garin,et al.  Characterization of a novel RNA‐binding region of eIF4GI critical for ribosomal scanning , 2003, The EMBO journal.

[98]  Andrea M. Hanson,et al.  CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[99]  P. Cohen,et al.  Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase , 1996, FEBS letters.

[100]  S. Elledge,et al.  A family of mammalian F-box proteins , 1999, Current Biology.

[101]  Keiichi Fukuda,et al.  Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. , 2011, Cell metabolism.

[102]  C. Berset,et al.  The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[104]  P. Gluckman,et al.  The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. , 2012, Cell metabolism.

[105]  A. Gingras,et al.  Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E , 1999, The EMBO journal.

[106]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[107]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[108]  T. Hornberger,et al.  Faculty Opinions recommendation of Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. , 2014 .

[109]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[110]  Se-Jin Lee,et al.  Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways , 2007, PloS one.

[111]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[112]  S. Bhatnagar,et al.  The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice , 2010, The Journal of cell biology.

[113]  G. Meroni,et al.  TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[114]  C. Reggiani,et al.  Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[115]  Holly McDonough,et al.  Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. , 2007, The Journal of clinical investigation.

[116]  M. Sandri Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome☆☆☆ , 2013, The international journal of biochemistry & cell biology.

[117]  O. Mayans,et al.  Structural analysis of B-Box 2 from MuRF1: identification of a novel self-association pattern in a RING-like fold. , 2008, Biochemistry.

[118]  P. Freemont,et al.  Does this have a familiar RING? , 1996, Trends in biochemical sciences.

[119]  S. Rakhilin,et al.  The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. , 2007, Cell metabolism.

[120]  J. Tong,et al.  AMP‐activated protein kinase enhances the expression of muscle‐specific ubiquitin ligases despite its activation of IGF‐1/Akt signaling in C2C12 myotubes , 2009, Journal of cellular biochemistry.

[121]  S. Elledge,et al.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.

[122]  D. Bolster,et al.  AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling* , 2002, The Journal of Biological Chemistry.

[123]  G. Condorelli,et al.  The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[124]  H. Granzier,et al.  MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance. , 2010, Journal of structural biology.

[125]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[126]  M. Fornaro,et al.  Gαi2 Signaling Promotes Skeletal Muscle Hypertrophy, Myoblast Differentiation, and Muscle Regeneration , 2011, Science Signaling.

[127]  S. Welle,et al.  Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[128]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[129]  R. Berdeaux,et al.  cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration. , 2012, American journal of physiology. Endocrinology and metabolism.

[130]  A. Russell,et al.  Peroxisome Proliferator-activated Receptor γ Coactivator 1 (PGC-1)- and Estrogen-related Receptor (ERR)-induced Regulator in Muscle 1 (PERM1) Is a Tissue-specific Regulator of Oxidative Capacity in Skeletal Muscle Cells* , 2013, The Journal of Biological Chemistry.

[131]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[132]  Se-Jin Lee,et al.  Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.

[133]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[134]  B. Viollet,et al.  Important role for AMPKαl in limiting skeletal muscle cell hypertrophy , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[135]  Daiwen Chen,et al.  Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. , 2007, Cellular signalling.

[136]  G. Scheper,et al.  The Mitogen-Activated Protein Kinase Signal-Integrating Kinase Mnk2 Is a Eukaryotic Initiation Factor 4E Kinase with High Levels of Basal Activity in Mammalian Cells , 2001, Molecular and Cellular Biology.

[137]  J. Lagirand-Cantaloube,et al.  Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo , 2009, PloS one.

[138]  Valerie Horsley,et al.  NFAT: ubiquitous regulator of cell differentiation and adaptation. , 2002, The Journal of cell biology.

[139]  Sherry Chin,et al.  MNK2 Inhibits eIF4G Activation Through a Pathway Involving Serine-Arginine–Rich Protein Kinase in Skeletal Muscle , 2012, Science Signaling.

[140]  R. Roubenoff,et al.  Recent advances in the biology and therapy of muscle wasting , 2010, Annals of the New York Academy of Sciences.

[141]  J. Olefsky,et al.  A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.

[142]  Christian C Witt,et al.  Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2 , 2007, The EMBO journal.

[143]  C. Jacobi,et al.  TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A , 2012, Skeletal Muscle.

[144]  C. Greenberg,et al.  Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. , 2002, American journal of human genetics.

[145]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[146]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[147]  Alexandros Tzatsos,et al.  Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation , 2006, Molecular and Cellular Biology.

[148]  V. Sirri,et al.  Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase* , 2005, Journal of Biological Chemistry.

[149]  Qicheng Ma,et al.  Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement. , 2011, American journal of physiology. Endocrinology and metabolism.

[150]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.